U.S. COVID-19 breakthrough infections are 'uncommon,' rising 'considerably,' and 'sort of okay'

The Biden administration is advising eight-month booster shots for Americans vaccinated with the Pfizer and Moderna COVID-19 vaccines because the Delta variant, which now accounts for about 98.8 percent of new U.S. infections, is a lot more contagious and the effectiveness of the vaccines appears to wane with time.
"Fortunately," the COVID-19 vaccines are "still holding at a high level" of protection from hospitalization and death, Surgeon General Vivek Murthy said Wednesday. "But our anticipation is that if the trajectory that we are seeing continues ... we will likely see in the future an increase in breakthrough hospitalizations and breakthrough deaths" without boosters.
Even as the Delta variant surges, "COVID-19 breakthrough cases remain uncommon," The Wall Street Journal reports, citing its own analysis of data from health departments in 44 states and Washington, D.C. In those states, about 0.1 percent of vaccinated residents got COVID between Jan. 1 and early August, the Journal found.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"This continues to be 'a pandemic of the unvaccinated,'" but "breakthrough infections accounted for 12 percent to 24 percent of COVID-related hospitalizations" in seven states keeping detailed records, The New York Times reports, citing its analysis. Those breakthrough cases are mostly among older or immunocompromised adults — in Oregon, for example, the median age for a breakthrough-associated death is 83, and 74 percent of breakthrough cases nationwide are among people 65 and older, federal data show.
The overall numbers remain small, but it's pretty clear "the chances of a breakthrough infection have gone up considerably," U.C. San Francisco's Dr. Robert Wachter tells the Times. "Remember when the early vaccine studies came out, it was like nobody gets hospitalized, nobody dies," he added. "That clearly is not true."
"Let's be real, here: Breakthrough infections are sort of okay," Larry Corey, a virologist at Seattle's Fred Hutchinson Cancer Research Center, tells the Journal. "You get infected and you have a cold, maybe an achy fever for 24 hours. But you don't end up in the hospital, and you don't end up with that 2.5 percent chance of dying once you are hospitalized."
"All we're really seeing, with vaccine breakthrough cases that come into the hospital, are people who are over 80 or have a compromised immune system," adds Jorge Bernett, an infectious disease specialist with John Muir Health in Walnut Creek, California. "Basically everyone who is on a ventilator is unvaccinated."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Javier Milei's memecoin scandal
Under The Radar Argentinian president is facing impeachment calls and fraud accusations
By Chas Newkey-Burden, The Week UK Published
-
Who is actually running DOGE?
TODAY'S BIG QUESTION The White House said in a court filing that Elon Musk isn't the official head of Donald Trump's Department of Government Efficiency task force, raising questions about just who is overseeing DOGE's federal blitzkrieg
By Rafi Schwartz, The Week US Published
-
How does the Kennedy Center work?
The Explainer The D.C. institution has become a cultural touchstone. Why did Trump take over?
By Joel Mathis, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published